$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach
Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now